The University of Alabama at Birmingham proposes to coordinate a three-site HPTU in Lusaka, Zambia, Port- au-Prince, Haiti, and in Birmingham. The emphasis of the proposal is to find cost-effective strategies for HIV prevention emphasizing mother to child transmission, barrier/microbicide research, STD control, and linked behavior change work. Specific research concepts are presented in this proposal. UAB is joined by collaborators from four US schools of medicine/public health (Cornell, Harvard, Miami, Vanderbilt); the oldest HIV/AIDS non-governmental agency in Haiti (GHESKIO); and multiple governmental and non-governmental entities in Zambia including the District Health Board (responsible for the large network of Lusaka primary care clinics), the University Teaching Hospital, the Virology Laboratory, and the University of Zambia School of Medicine. Expatriate staff working on all trials abroad will do so under the field policy direction of the on-site study directors, Drs. Moses Sinkala and Chewe Luo in Zambia, Jean Pape in Haiti. Existing cohorts suitable for immediate research consideration include: pregnant women in Lusaka clinics, discordant couples in both Lusaka and Port-au-Prince, low- and high-risk women in barrier method studies in Birmingham, and persons with tuberculosis and STDs in Port-au-Prince. The Birmingham site will extend our existing studies of inner city women enrolled in studies of female condoms and microbicides, perhaps the largest such active cohort in the US. A collaboration with the AVEU/HVTU at UAB (M. Mulligan, Principal Investigator) and Vanderbilt (P. Wright, Principal Investigator) for Zambia and Haiti collaboration respectively, ensures maximum potential for pediatric vaccine trials. The Principal Investigator (S. Vermund) of this collaborative HPTU presentation is on both the Executive Committee and the Prevention Leadership Group of the HPTN, facilitating maximum communication and coordination. Management structures, ethics review committees and processes, community advisory boards, and scientific oversight Committees are in place. Support from national and local officials in Zambia and Haiti is documented. The application describes field scientific and logistical experience that suggests the three sites will continue to function at a high level, even in impoverished settings that do present specific challenges. Since other research and service funding supports these cohorts, the costs to maintain them prior to trials beginning are minimal.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-KWR-A (M1))
Program Officer
Chow, Grace C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Alabama Birmingham
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Hoffman, Susie; Morrow, Kate M; Mantell, Joanne E et al. (2010) Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial. Arch Sex Behav 39:748-60
Stringer, Elizabeth; Read, Jennifer S; Hoffman, Irving et al. (2010) Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. S Afr Med J 100:58-64
Chen, Ying Q; Young, Alicia; Brown, Elizabeth R et al. (2010) Population attributable fractions for late postnatal mother-to-child transmission of HIV-1 in Sub-Saharan Africa. J Acquir Immune Defic Syndr 54:311-6
Kilewo, C; Natchu, U C M; Young, A et al. (2009) Hypertension in pregnancy among HIV-infected women in sub-Saharan Africa: prevalence and infant outcomes. Afr J Reprod Health 13:25-36
Kapina, Muzala; Reid, Cheri; Roman, Karisse et al. (2009) HIV incidence rates and risk factors for urban women in Zambia: preparing for a microbicide clinical trial. Sex Transm Dis 36:129-33
Msamanga, Gernard I; Taha, Taha E; Young, Alicia M et al. (2009) Placental malaria and mother-to-child transmission of human immunodeficiency virus-1. Am J Trop Med Hyg 80:508-15
Aboud, Said; Msamanga, Gernard; Read, Jennifer S et al. (2009) Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia. Int J Gynaecol Obstet 107:202-7
Kafulafula, George; Mwatha, Anthony; Chen, Ying Qing et al. (2009) Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa. Pediatrics 124:e137-44
Nelson, Julie A E; Loftis, Amy M; Kamwendo, Deborah et al. (2009) Nevirapine resistance in human immunodeficiency virus type 1-positive infants determined using dried blood spots stored for up to six years at room temperature. J Clin Microbiol 47:1209-11
Read, Jennifer S; Mwatha, Anthony; Richardson, Barbra et al. (2009) Primary HIV-1 infection among infants in sub-Saharan Africa: HPTN 024. J Acquir Immune Defic Syndr 51:317-22

Showing the most recent 10 out of 36 publications